Knight Therapeutics Inc.
TSX:GUD.TO · Toronto Stock Exchange
+$0.07 today
Vol 0.04M · Avg 0.10M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $108.0M |
| Short-term Investments | $19.2M |
| Receivables | $156.6M |
| Inventory | $141.9M |
| Other Current | $21.1M |
| Total Current Assets | $447.0M |
| PP&E (Net) | $30.4M |
| Goodwill | $95.3M |
| Intangible Assets | $354.0M |
| Long-term Investments | $123.7M |
| Tax Assets | $26.7M |
| Other Non-current | $9.5M |
| Total Non-current Assets | $639.6M |
| Total Assets | $1.1B |
Analysis
Selected assets total $1.1B for Latest. The largest visible component is Intangible Assets at $354.0M, about 32.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $76.4M -4.6% | $80.1M +36.3% | $58.8M -18.0% | $71.7M -16.6% | $86.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $18.8M -79.7% | $92.7M -3.1% | $95.7M -20.0% | $119.5M +55.2% | $77.0M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $138.2M +21.8% | $113.5M +15.6% | $98.2M -9.5% | $108.6M +61.0% | $67.4M | $533.8M | $399.4M | -$1.7B |
| Inventory | $135.9M +32.3% | $102.7M +11.8% | $91.8M -0.7% | $92.5M +27.8% | $72.4M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $18.9M +35.2% | $14.0M -11.0% | $15.8M -18.3% | $19.3M +720.7% | $2.4M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $394.8M -0.5% | $396.8M +8.7% | $365.1M -7.7% | $395.6M +28.7% | $307.3M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $21.9M +9.5% | $20.0M +12.1% | $17.9M -21.1% | $22.6M -24.4% | $29.9M | $1.2B | $1.5B | $687.8M |
| Goodwill | $90.0M +4.1% | $86.5M +8.3% | $79.8M -3.0% | $82.3M +9.1% | $75.4M | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $379.5M +33.8% | $283.6M -2.2% | $290.0M -14.4% | $338.8M -3.3% | $350.3M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $124.2M +20.1% | $103.4M -13.8% | $120.0M -24.0% | $158.0M -11.7% | $179.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $26.9M +26.7% | $21.2M +9.6% | $19.4M +108.3% | $9.3M +354.6% | $2.0M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $8.9M -83.0% | $52.2M -2.1% | $53.3M +10.6% | $48.2M +0.6% | $47.9M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $651.5M +14.9% | $567.0M -2.3% | $580.4M -12.0% | $659.2M -3.7% | $684.6M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $1.0B +8.6% | $963.8M +1.9% | $945.5M -10.4% | $1.1B +6.3% | $991.9M | $13.3B | $11.9B | $10.6B |
| Account Payables | $120.9M +54.3% | $78.3M -8.2% | $85.4M -19.5% | $106.1M +62.4% | $65.3M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $20.1M +15.1% | $17.5M -2.0% | $17.9M +1.0% | $17.7M -33.7% | $26.7M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $213.0K -82.0% | $1.2M -48.0% | $2.3M -67.8% | $7.1M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 -100.0% | $9.7M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $20.3M +981.3% | $1.9M -76.3% | $7.9M -47.3% | $15.0M +654.6% | $2.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $165.3M +48.6% | $111.2M -2.4% | $114.0M -19.3% | $141.3M +34.2% | $105.3M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $51.2M +97.6% | $25.9M -41.2% | $44.0M -16.0% | $52.4M +465.5% | $9.3M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $3.0M -22.1% | $3.8M +36.3% | $2.8M -35.5% | $4.4M -64.7% | $12.4M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $53.0M +118.3% | $24.3M -24.8% | $32.3M +24.8% | $25.8M +32.4% | $19.5M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $113.8M +98.1% | $57.4M -32.1% | $84.6M -3.5% | $87.7M +96.7% | $44.6M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $279.0M +65.4% | $168.7M -15.1% | $198.6M -13.3% | $229.0M +52.8% | $149.9M | $14.7B | $3.7B | $9.6B |
| Common Stock | $530.1M -0.8% | $534.3M -1.1% | $540.0M -9.9% | $599.1M -4.7% | $628.9M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $148.9M -3.8% | $154.8M +2.6% | $150.9M -6.7% | $161.8M -15.6% | $191.6M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $55.7M -30.5% | $80.2M +167.9% | $29.9M -27.6% | $41.4M +16078.0% | -$259.0K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 -100.0% | $117.0K | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $767.3M -3.5% | $795.1M +6.5% | $746.9M -9.6% | $825.9M -1.9% | $842.0M | $9.1B | $7.7B | $3.3B |
| Total Debt | $77.9M +57.5% | $49.5M -28.4% | $69.1M -11.1% | $77.7M +89.7% | $41.0M | $724.2M | $410.6M | $399.4M |
| Net Debt | $1.5M +104.8% | -$30.6M -396.7% | $10.3M +71.6% | $6.0M +113.4% | -$45.0M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Bright Minds Biosciences Inc.
DRUG.CN
$650.96M
Kneat.com, Inc.
TSX:KSI.TO
$618.13M
Verano Holdings Corp.
VRNO.NE
$594.30M
Vitalhub Corp.
TSX:VHI.TO
$453.89M
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
$408.04M
Cresco Labs Inc.
CL.CN
$407.36M
TerrAscend Corp.
TSX:TSND.TO
$284.80M
Canopy Growth Corporation
TSX:WEED.TO
$244.44M
Aurora Cannabis Inc.
TSX:ACB.TO
$234.78M
OrganiGram Holdings Inc.
TSX:OGI.TO
$189.01M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does GUD.TO have?
Knight Therapeutics Inc. (GUD.TO) reported $76.45M in cash and equivalents in fiscal 2025.
How much debt does GUD.TO carry?
Knight Therapeutics Inc. (GUD.TO) reported $77.91M of total debt, with net debt of $1.46M.
Explore More
Continue the stock analysis
Jump to another research area for this company.